Verdemed, a Brazilian pharmaceutical company, has recently solidified its authority in the growing cannabis-based medication market with multiple approvals from Anvisa. Verdemed presents a range of products, including a solution similar to Jazz Pharmaceuticals' Epidiolex, which contributes to the rising demand for cannabis-based medicinal alternatives in Brazil.
by Fiscal Beat Staff | Aug 23, 2023